Literature DB >> 23728460

Control of metastatic progression by microRNA regulatory networks.

Nora Pencheva1, Sohail F Tavazoie.   

Abstract

Aberrant microRNA (miRNA) expression is a defining feature of human malignancy. Specific miRNAs have been identified as promoters or suppressors of metastatic progression. miRNAs control metastasis through divergent or convergent regulation of metastatic gene pathways. Some miRNA regulatory networks govern cell-autonomous cancer phenotypes, whereas others modulate the cell-extrinsic composition of the metastatic microenvironment. The use of small RNAs as probes into the molecular and cellular underpinnings of metastasis holds promise for the identification of candidate genes for potential therapeutic intervention.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23728460      PMCID： PMC4678324          DOI： 10.1038/ncb2769

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


  135 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.

Authors:  Kim J Png; Mitsukuni Yoshida; Xiang H-F Zhang; Weiping Shu; Hyeseung Lee; Andreas Rimner; Timothy A Chan; Elizabeth Comen; Viktor P Andrade; Seok Won Kim; Tari A King; Clifford A Hudis; Larry Norton; James Hicks; Joan Massagué; Sohail F Tavazoie
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

3.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

4.  Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.

Authors:  Jieun Yun; Casey A Frankenberger; Wen-Liang Kuo; Mirjam C Boelens; Eva M Eves; Nancy Cheng; Han Liang; Wen-Hsiung Li; Hemant Ishwaran; Andy J Minn; Marsha Rich Rosner
Journal:  EMBO J       Date:  2011-08-26       Impact factor: 11.598

5.  A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.

Authors:  Kim J Png; Nils Halberg; Mitsukuni Yoshida; Sohail F Tavazoie
Journal:  Nature       Date:  2011-12-14       Impact factor: 49.962

6.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  A MicroRNA expression profile defining the invasive bladder tumor phenotype.

Authors:  Matthew F Wszolek; Kimberly M Rieger-Christ; Patrick A Kenney; Justin J Gould; Brasil Silva Neto; Amanda K Lavoie; Tanya Logvinenko; John A Libertino; Ian C Summerhayes
Journal:  Urol Oncol       Date:  2009-11-27       Impact factor: 3.498

8.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

9.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807
View more
  156 in total

1.  MicroRNA MIR21 and T Cells in Colorectal Cancer.

Authors:  Kosuke Mima; Reiko Nishihara; Jonathan A Nowak; Sun A Kim; Mingyang Song; Kentaro Inamura; Yasutaka Sukawa; Atsuhiro Masuda; Juhong Yang; Ruoxu Dou; Katsuhiko Nosho; Hideo Baba; Edward L Giovannucci; Michaela Bowden; Massimo Loda; Marios Giannakis; Adam J Bass; Glenn Dranoff; Gordon J Freeman; Andrew T Chan; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Cancer Immunol Res       Date:  2015-09-29       Impact factor: 11.151

2.  Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes "microRNA-like" tRNA Fragments.

Authors:  Nicole Guzman; Kitty Agarwal; Dilip Asthagiri; Lianbo Yu; Motoyasu Saji; Matthew D Ringel; Michael E Paulaitis
Journal:  Mol Cancer Res       Date:  2015-02-26       Impact factor: 5.852

Review 3.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

4.  The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.

Authors:  Lina Wang; Ting Yu; Wei Li; Mengmeng Li; Qianfei Zuo; Quanming Zou; Bin Xiao
Journal:  Oncogene       Date:  2019-01-09       Impact factor: 9.867

Review 5.  The emerging molecular machinery and therapeutic targets of metastasis.

Authors:  Yutong Sun; Li Ma
Journal:  Trends Pharmacol Sci       Date:  2015-05-01       Impact factor: 14.819

Review 6.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 7.  Long Non-coding RNAs and their Role in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

Review 8.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

9.  microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.

Authors:  Michal J Besser; Gal Markel; Gilli Galore-Haskel; Eyal Greenberg; Inbal Yahav; Ettai Markovits; Rona Ortenberg; Ronnie Shapira-Fromer; Orit Itzhaki; Jacob Schachter
Journal:  Cancer Immunol Immunother       Date:  2020-11-17       Impact factor: 6.968

10.  miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.

Authors:  Xiaoling She; Zhibin Yu; Yulong Cui; Qianqian Lei; Zeyou Wang; Gang Xu; Zhaohui Luo; Guiyuan Li; Minghua Wu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.